Exact Sciences
Developer and manufacturer of cologuard, a non-invasive screening test for the early detection of colorectal cancer. Learn more
Launch date
Employees
Market cap
AUD19.2b
Enterprise valuation
AUD22.1b (Public information from Sep 2024)
Share price
$70.83 EXAS
Madison Wisconsin (HQ)
Authorizing premium user...